FOSNETUPITANT (AS CHLORIDE HYDROCHLORIDE)/PALONOSETRON (AS HYDROCHLORIDE)

Information current as at: 1 June 2026

No activity by the pharmaceutical company has been recorded for this medicine for six(6) months. The process for listing is considered inactive.


Legend: Completed N In progress Not applicable N Yet to commence

Submission Details

Brand name:
  • AKYNZEO IV®
Form and strength:
Please search for and view the medicine's Public Summary Document (PSD) for more information
Submission sponsor:
Mundipharma Pty Limited
Condition/indication:
(therapeutic use)
  • Nausea and vomiting
Listing requested:
Please see PSD for more information
Funding program:
Please see PSD for more information
Request authority level:
Please see PSD for more information
PBAC Submission type:
New listing (Minor)
Comment:
--
Other PBAC consideration:
--

Progress Details

Submission received for:
July 2020 PBAC meeting
Opportunity for consumer comment:
Open 29/04/2020 and close 10/06/2020 (see PBS Website)
PBAC meeting:
Held on 08/07/2020
PBAC outcome published:
Recommended (see PBAC Outcomes)
Notice of intent submitted:
10/09/2020
Lodgement of required documentation:
07/10/2020
Acceptance of complete documentation:
Accepted
Agreement to listing arrangements:
Not applicable
Government processes:
Not applicable
Medicine listed on the PBS:
Not applicable

PBAC Outcome

PBAC Recommendation:
Please see the Outcomes from the relevant meeting for more information

Case ID
a186
Page last updated
31 March 2026
v.9.19